1. Home
  2. OZK vs LQDA Comparison

OZK vs LQDA Comparison

Compare OZK & LQDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bank OZK

OZK

Bank OZK

HOLD

Current Price

$53.01

Market Cap

5.5B

Sector

Finance

ML Signal

HOLD

LQDA

Liquidia Corporation

HOLD

Current Price

$73.94

Market Cap

5.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OZK
LQDA
Founded
1903
2004
Country
United States
United States
Employees
3351
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.5B
5.5B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
OZK
LQDA
Price
$53.01
$73.94
Analyst Decision
Buy
Strong Buy
Analyst Count
10
11
Target Price
$55.00
$41.00
AVG Volume (30 Days)
1.3M
2.1M
Earning Date
04-21-2026
05-08-2026
Dividend Yield
3.87%
N/A
EPS Growth
N/A
51.81
EPS
N/A
0.52
Revenue
N/A
$158,320,000.00
Revenue This Year
$12.84
$278.87
Revenue Next Year
$6.32
$57.13
P/E Ratio
$8.01
$148.37
Revenue Growth
N/A
1031.18
52 Week Low
$42.37
$14.25
52 Week High
$53.66
$82.96

Technical Indicators

Market Signals
Indicator
OZK
LQDA
Relative Strength Index (RSI) 63.86 51.10
Support Level $45.99 $70.85
Resistance Level N/A $82.96
Average True Range (ATR) 1.14 4.50
MACD 0.06 -1.30
Stochastic Oscillator 90.95 30.34

Price Performance

Historical Comparison
OZK
LQDA

About OZK Bank OZK

Bank OZK is a bank holding company that owns and operates a community bank, Bank of the Ozarks. The bank operates offices in Arkansas, Georgia, Florida, North Carolina, Texas, California, New York and Mississippi. It provides banking services, including checking, savings, money market, time deposits, and individual retirement accounts, as well as loan services, such as real estate, consumer, commercial, and industrial loans. Apart from providing traditional banking products and services, it also provides trust and wealth management, financial planning, online banking, and other related services.

About LQDA Liquidia Corporation

Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also conducting studies on L606, an investigational, liposomal formulation of treprostinil.

Share on Social Networks: